Thinking and quality of life in retinoblastoma survivors
Part of Cancer, Eyes & vision, Mental health clinical trials.
This study looks at how retinoblastoma and its treatment affect thinking skills and quality of life over time. It may help doctors better support survivors and their families.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with retinoblastoma or were a carrier at risk and treated or screened at the Dutch Retinoblastoma Expertise Center in Amsterdam.
- You are between 8 and 35 years old.
- You can understand Dutch well enough for conversations and questionnaires.
- You do not have a known severe learning disability or serious untreated mental health condition.
- Your retinoblastoma care was not received at another hospital or before 1991, unless you also had specialized treatment at another center.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at long-term health outcomes—how patients are doing physically and in daily life—after treatment for retinoblastoma. It may help doctors understand what support or follow-up care could be most helpful after treatment.
This study looks at whether having anesthesia more than once (for eye/surgery treatment) affects children’s thinking and learning. It may help doctors plan safer care and better follow-up for children with retinoblastoma.
This trial looks at care recommendations for children with retinoblastoma (a childhood eye cancer). It may help standardize the best treatment approach for different patterns of tumor spread.
This trial studies whether newer “save-the-eye” treatment plans can control retinoblastoma (eye cancer) while keeping vision as good as possible. It compares different conservative treatment strategies depending on how the tumor looks and where it is.
This study looks at patients who have received additional cancer treatment after their initial retinoblastoma (eye cancer) therapy and tracks their recovery for at least one year. The research aims to understand how well this follow-up treatment works and what happens to patients over time.
This study follows people who have had advanced cancer and are now stable after immunotherapy, to see how thinking, mood, and daily life change over time. Some participants may also do an integrative brain-training program if they have memory or thinking problems.
Hear when a new Retinoblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.